Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × pertuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Neoplasms 5 Neoplasm Metastasis 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 HER2-positive Early Breast Cancer 2 HER2-positive Breast Cancer 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Patient Preference 1 Pathologic Complete Response 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Malignant Solid Neoplasm 1 Liver Neoplasms 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Early-stage Breast Cancer 1 Gastrointestinal Neoplasms 1 Early-stage or Locally Advanced HER2-positive Breast Cancer 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡